{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:56:45Z","timestamp":1793105805507,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Inserm","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-026-00880-7","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:45:16Z","timestamp":1780497916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma PF4 is a reliable biomarker of platelet reactivity and predictive of bleeding risk in DAPT patients undergoing cardiac surgery"],"prefix":"10.1186","volume":"24","author":[{"given":"Joseph Roux","family":"de Bezieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Amour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Rancic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gendron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Bertil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Gaussem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Smadja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"880_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.thromres.2004.07.020","volume":"114","author":"RK Andrews","year":"2004","unstructured":"Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res. 2004;114:447\u201353.","journal-title":"Thromb Res"},{"key":"880_CR2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1055\/s-0037-1603366","volume":"43","author":"EC Hansson","year":"2017","unstructured":"Hansson EC, Jeppsson A, Antiplatelet Therapy. Platelet Function Testing, and Bleeding Complications in Cardiac Surgery Patients. Semin Thromb Hemost. 2017;43:699\u2013705.","journal-title":"Semin Thromb Hemost"},{"key":"880_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijcard.2018.07.083","volume":"269","author":"R Cardoso","year":"2018","unstructured":"Cardoso R, et al. Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis. Int J Cardiol. 2018;269:80\u20138.","journal-title":"Int J Cardiol"},{"key":"880_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/ejcts\/ezw149","volume":"50","author":"A Tom\u0161i\u010d","year":"2016","unstructured":"Tom\u0161i\u010d A, Schotborgh MA, Manshanden JSJ, Li WWL, De Mol BA. J. M. Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment. Eur J Cardiothorac Surg. 2016;50:849\u201356.","journal-title":"Eur J Cardiothorac Surg"},{"key":"880_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jjcc.2016.02.013","volume":"69","author":"Z Nagashima","year":"2017","unstructured":"Nagashima Z, et al. Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting. J Cardiol. 2017;69:156\u201361.","journal-title":"J Cardiol"},{"key":"880_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/bja\/aew357","volume":"117","author":"J Amour","year":"2016","unstructured":"Amour J, et al. Prospective observational study of the effect of dual antiplatelet therapy with tranexamic acid treatment on platelet function and bleeding after cardiac surgery. Br J Anaesth. 2016;117:749\u201357.","journal-title":"Br J Anaesth"},{"key":"880_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4330\/wjc.v7.i9.571","volume":"7","author":"V Tarzia","year":"2015","unstructured":"Tarzia V, et al. Single vs double antiplatelet therapy in acute coronary syndrome: Predictors of bleeding after coronary artery bypass grafting. World J Cardiol. 2015;7:571\u20138.","journal-title":"World J Cardiol"},{"key":"880_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1055\/s-0038-1641153","volume":"118","author":"E Mahla","year":"2018","unstructured":"Mahla E, et al. Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study. Thromb Haemost. 2018;118:864\u201372.","journal-title":"Thromb Haemost"},{"key":"880_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.acvd.2021.06.003","volume":"114","author":"BD Sollier","year":"2021","unstructured":"Sollier BD. Is platelet function testing at the acute phase under P2Y12 inhibitors helpful in predicting bleeding in real-life patients with acute coronary syndrome? The AVALANCHE study. Arch Cardiovasc Dis. 2021;114:612\u201323.","journal-title":"Arch Cardiovasc Dis"},{"key":"880_CR10","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.3390\/jcm12134530","volume":"12","author":"B Chyrchel","year":"2023","unstructured":"Chyrchel B, Kruszelnicka O, Wieczorek-Surdacka E, Surdacki A. Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet Therapy. J Clin Med. 2023;12:4530.","journal-title":"J Clin Med"},{"key":"880_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/nu13020286","volume":"13","author":"A Ntzouvani","year":"2021","unstructured":"Ntzouvani A, et al. Effect of Differently Fed Farmed Gilthead Sea Bream Consumption on Platelet Aggregation and Circulating Haemostatic Markers among Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial. Nutrients. 2021;13:286.","journal-title":"Nutrients"},{"key":"880_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.thromres.2023.01.012","volume":"223","author":"D Mehic","year":"2023","unstructured":"Mehic D, et al. Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia. Thromb Res. 2023;223:102\u201310.","journal-title":"Thromb Res"},{"key":"880_CR13","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.rpth.2023.100101","volume":"7","author":"OCD Liesdek","year":"2023","unstructured":"Liesdek OCD, et al. Acquired blood platelet disorder in patients with end-stage heart failure after implantation of a continuous centrifugal-flow left ventricular assist device: A prospective cohort study. Res Pract Thromb Haemost. 2023;7:100101.","journal-title":"Res Pract Thromb Haemost"},{"key":"880_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/08860220802599163","volume":"31","author":"G Sahin","year":"2009","unstructured":"Sahin G, et al. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients. Ren Fail. 2009;31:111\u20137.","journal-title":"Ren Fail"},{"key":"880_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1067\/mhj.2002.119372","volume":"143","author":"H-J Seyfarth","year":"2002","unstructured":"Seyfarth H-J, et al. Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation. Am Heart J. 2002;143:118\u201323.","journal-title":"Am Heart J"},{"key":"880_CR16","doi-asserted-by":"publisher","first-page":"684920","DOI":"10.3389\/fcvm.2021.684920","volume":"8","author":"G Baidildinova","year":"2021","unstructured":"Baidildinova G, et al. Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease. Front Cardiovasc Med. 2021;8:684920.","journal-title":"Front Cardiovasc Med"},{"key":"880_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1165\/rcmb.2015-0245OC","volume":"56","author":"K Bdeir","year":"2017","unstructured":"Bdeir K, et al. Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury. Am J Respir Cell Mol Biol. 2017;56:261\u201370.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"880_CR18","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1111\/jth.14555","volume":"17","author":"K Horioka","year":"2019","unstructured":"Horioka K, et al. Hypothermia-induced activation of the splenic platelet pool as a risk factor for thrombotic disease in a mouse model. J Thromb Haemost. 2019;17:1762\u201371.","journal-title":"J Thromb Haemost"},{"key":"880_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1084\/jem.171.2.449","volume":"171","author":"A Walz","year":"1990","unstructured":"Walz A, Baggiolini M. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. J Exp Med. 1990;171:449\u201354.","journal-title":"J Exp Med"},{"key":"880_CR20","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood-2003-11-3994","volume":"104","author":"DE Eslin","year":"2004","unstructured":"Eslin DE, et al. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood. 2004;104:3173\u201380.","journal-title":"Blood"},{"issue":"Suppl 2","key":"880_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ijlh.14075","volume":"45","author":"A Greinacher","year":"2023","unstructured":"Greinacher A, Warkentin TE. Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity. Int J Lab Hematol. 2023;45(Suppl 2):11\u201322.","journal-title":"Int J Lab Hematol"},{"key":"880_CR22","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1182\/blood-2002-07-2149","volume":"101","author":"A Dupont","year":"2003","unstructured":"Dupont A, et al. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood. 2003;101:1833\u201340.","journal-title":"Blood"},{"key":"880_CR23","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1373\/clinchem.2007.089102","volume":"53","author":"S Clauser","year":"2007","unstructured":"Clauser S, et al. Development of a Novel Immunoassay for the Assessment of Plasma Gas6 Concentrations and Their Variation with Hormonal Status. Clin Chem. 2007;53:1808\u201313.","journal-title":"Clin Chem"},{"key":"880_CR24","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3171\/2019.12.JNS192396","volume":"134","author":"BM Corliss","year":"2021","unstructured":"Corliss BM, et al. Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping. J Neurosurg. 2021;134:884\u201392.","journal-title":"J Neurosurg"},{"key":"880_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.amjcard.2022.01.057","volume":"171","author":"I Cavallari","year":"2022","unstructured":"Cavallari I, et al. Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status. Am J Cardiol. 2022;171:49\u201354.","journal-title":"Am J Cardiol"},{"key":"880_CR26","doi-asserted-by":"publisher","first-page":"106631","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106631","volume":"31","author":"K Fujita","year":"2022","unstructured":"Fujita K, et al. P2Y12 reaction units and ischemic and bleeding events after neuro-endovascular treatment. J Stroke Cerebrovasc Dis. 2022;31:106631.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"880_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MCA.0000000000001336","volume":"35","author":"B Ramotowski","year":"2024","unstructured":"Ramotowski B, Lewandowski P, S\u0142omski T, Maciejewski P, Budaj A. Platelet reactivity and activated clotting time predict hemorrhagic site complications in patients with chronic coronary syndromes undergoing percutaneous coronary interventions. Coron Artery Dis. 2024;35:292\u20138.","journal-title":"Coron Artery Dis"},{"key":"880_CR28","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","volume":"367","author":"J-P Collet","year":"2012","unstructured":"Collet J-P, et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med. 2012;367:2100\u20139.","journal-title":"N Engl J Med"},{"key":"880_CR29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.thromres.2015.09.014","volume":"136","author":"M Nishikawa","year":"2015","unstructured":"Nishikawa M, et al. No association between on-treatment platelet reactivity and bleeding events following percutaneous coronary intervention and antiplatelet therapy: A post hoc analysis. Thromb Res. 2015;136:947\u201354.","journal-title":"Thromb Res"},{"key":"880_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3181\/00379727-198-43309","volume":"198","author":"MB Zucker","year":"1991","unstructured":"Zucker MB, Katz IR. Platelet Factor 4: Production, Structure, and Physiologic and Immunologic Action. Proc Soc Exp Biol Med. 1991;198:693\u2013702.","journal-title":"Proc Soc Exp Biol Med"},{"key":"880_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/MCA.0b013e328360efd3","volume":"24","author":"J Kaufmann","year":"2013","unstructured":"Kaufmann J, et al. Soluble P-selectin level correlates with acetylsalicylic acid but not with clopidogrel response in patients with stable coronary artery disease after a percutaneous coronary intervention. Coron Artery Dis. 2013;24:312.","journal-title":"Coron Artery Dis"},{"key":"880_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/rth2.12266","volume":"4","author":"J Rayes","year":"2020","unstructured":"Rayes J, Bourne JH, Brill A, Watson SP. The dual role of platelet-innate immune cell interactions in thrombo-inflammation. Res Pract Thromb Haemost. 2020;4:23\u201335.","journal-title":"Res Pract Thromb Haemost"},{"key":"880_CR33","doi-asserted-by":"publisher","first-page":"109201","DOI":"10.1016\/j.thromres.2024.109201","volume":"244","author":"TP Lemmens","year":"2024","unstructured":"Lemmens TP, et al. Platelet collagen receptors and their role in modulating platelet adhesion patterns and activation on alternatively processed collagen substrates. Thromb Res. 2024;244:109201.","journal-title":"Thromb Res"},{"key":"880_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1160\/TH14-11-0943","volume":"114","author":"WC Schrottmaier","year":"2015","unstructured":"Schrottmaier WC, Kral JB, Badrnya S, Assinger A. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes. Thromb Haemost. 2015;114:478\u201389.","journal-title":"Thromb Haemost"},{"key":"880_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/s-2007-996108","volume":"23","author":"K Schr\u00f6r","year":"1997","unstructured":"Schr\u00f6r K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost. 1997;23:349\u201356.","journal-title":"Semin Thromb Hemost"},{"key":"880_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01974942","volume":"21","author":"S Adnot","year":"1987","unstructured":"Adnot S, Joseph D, Vargaftig BB. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. Agents Actions. 1987;21:195\u2013202.","journal-title":"Agents Actions"},{"key":"880_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11239-023-02937-0","volume":"57","author":"D Gjermeni","year":"2024","unstructured":"Gjermeni D, et al. Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study. J Thromb Thrombolysis. 2024;57:361\u20139.","journal-title":"J Thromb Thrombolysis"},{"key":"880_CR38","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/MAT.0000000000002241","volume":"71","author":"DM Smadja","year":"2025","unstructured":"Smadja DM, et al. Platelet Activation and Severe Bleeding During Extracorporeal Carbon Dioxide Removal in Chronic Obstructive Pulmonary Disease Patients. ASAIO J. 2025;71:e20\u20132.","journal-title":"ASAIO J"},{"key":"880_CR39","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/cpt.2106","volume":"109","author":"L Traby","year":"2021","unstructured":"Traby L, et al. Differential Effects of Clopidogrel With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers. Clin Pharmacol Ther. 2021;109:1546\u201354.","journal-title":"Clin Pharmacol Ther"},{"key":"880_CR40","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1001\/jama.2023.23204","volume":"330","author":"MR Mehra","year":"2023","unstructured":"Mehra MR, et al. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure. JAMA. 2023;330:2171\u201381.","journal-title":"JAMA"},{"key":"880_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.4849","author":"F Gustafsson","year":"2025","unstructured":"Gustafsson F, et al. Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial. JAMA Cardiol. 2025. https:\/\/doi.org\/10.1001\/jamacardio.2024.4849.","journal-title":"JAMA Cardiol"},{"key":"880_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.amjcard.2010.08.068","volume":"107","author":"SC Goncalves","year":"2011","unstructured":"Goncalves SC, et al. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention. Am J Cardiol. 2011;107:204\u20139.","journal-title":"Am J Cardiol"},{"key":"880_CR43","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3390\/jcm9082361","volume":"9","author":"A Mansour","year":"2020","unstructured":"Mansour A, et al. Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet-Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation. J Clin Med. 2020;9:2361.","journal-title":"J Clin Med"},{"key":"880_CR44","first-page":"2639","volume":"17","author":"DJ Angiolillo","year":"2024","unstructured":"Angiolillo DJ, et al. International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update. JACC: Cardiovasc Interventions. 2024;17:2639\u201363.","journal-title":"JACC: Cardiovasc Interventions"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-026-00880-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00880-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00880-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:02:53Z","timestamp":1780563773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-026-00880-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1186\/s12959-026-00880-7","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study obtained ethical committee approval from Comit\u00e9 de Protection des Personnes VI - Ile de France Registration Date: December 2009 and has been published on ClinicalTrials.gov ID NCT01216150.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}